SLRX stock

Salarius Pharmaceuticals Inc (SLRX) financials · $4.9M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Salarius Pharmaceuticals Inc (SLRX) $4.9M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$12.6M-$5.73M
Net Income-$12.5M-$5.58M
EPS (Diluted)-$129.10-$5.79
Cached annual balance sheet
LineFY2025FY2024
Total Assets$11.1M$3.02M
Current Assets$11.0M$2.99M
Cash & Equivalents$10.7M$2.43M
PP&E$40.6KN/A
Total Liabilities$5.17M$1.51M
Current Liabilities$5.17M$1.51M
Shareholders' Equity$5.89M$1.51M
Retained Earnings-$94.4M-$81.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$4.83M-$4.53M
CapEx$577.0KN/A
Investing Cash Flow$764.7KN/A
Financing Cash Flow$12.3M$1.06M
Net Change in Cash$8.28M-$3.47M
Free Cash Flow-$5.40M-$4.53M
These statements as JSON? API free 100/day

FAQ

What is SLRX P/E and revenue?

Salarius Pharmaceuticals Inc (SLRX) $4.9M cap.

What is SLRX revenue?

SLRX income-statement cache has no revenue figure yet.

Is SLRX profitable?

Salarius Pharmaceuticals Inc last cached net income is -$12.5M (FY2025).

What are SLRX total assets?

Salarius Pharmaceuticals Inc last cached total assets are $11.1M (FY2025).

What is SLRX free cash flow?

Salarius Pharmaceuticals Inc last cached free cash flow is -$5.40M (FY2025).

Not investment advice. Cached statements, not a live tape.